Al lloc web de la Innovative Medicines Initiative (IMI2) podeu consultar els seminaris web dels topics de les convocatòries 22 i 23, que van obrir el 23 de juny. La convocatòra 22 està restringida a projectes finançats per IMI2 en convocatòries prèvies. La convocatòria 23 té els següents topics:

• Topic 1: Returning clinical trial data to study participants within a GDPR compliant and approved ethical framework
• Topic 2: Modelling the impact of monoclonal antibodies and vaccines on the reduction of antimicrobial resistance. This topic is part of IMI's Antimicrobial Resistance (AMR) Accelerator programme.
• Topic 3: A platform for accelerating biomarker discovery and validation to support therapeutics development for neurodegenerative diseases
• Topic 4: Optimal treatment for patients with solid tumours in Europe through artificial intelligence
• Topic 5 Shortening the path to rare disease diagnosis by using new born genetic screening and digital technologies
• Topic 6: Behavioural model of factors affecting patient adherence

Podeu accedir als seminaris des de: https://www.imi.europa.eu/news-events/events/imi2-call-22-23-webinars